Clinical Trial Update: Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bortezomib and dexamethasone with or without lenalidomide in patients with previously treated multiple myeloma was terminated, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2015-06-26